DE10026698A1
(de)
|
2000-05-30 |
2001-12-06 |
Basf Ag |
Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
|
US20030175342A1
(en)
*
|
2002-03-14 |
2003-09-18 |
Karl Kolter |
Coated pharmaceutical single-unit delayed-release forms, based on polyvinyl acetate
|
GB0209265D0
(en)
|
2002-04-23 |
2002-06-05 |
Novartis Ag |
Organic compounds
|
DE60323482D1
(de)
*
|
2002-05-06 |
2008-10-23 |
Massachusetts Inst Technology |
Diffusionskontrollierte arzneiform sowie herstellungsmethode mittels dreidimensionalem drucken
|
US7776314B2
(en)
|
2002-06-17 |
2010-08-17 |
Grunenthal Gmbh |
Abuse-proofed dosage system
|
JP2004147041A
(ja)
*
|
2002-10-24 |
2004-05-20 |
Mitsubishi Electric Corp |
検出回路及び復号回路
|
US8487002B2
(en)
|
2002-10-25 |
2013-07-16 |
Paladin Labs Inc. |
Controlled-release compositions
|
JP2006507277A
(ja)
*
|
2002-10-25 |
2006-03-02 |
ラボファーマ インコーポレイテッド |
24時間有効な持続放出トラマドール製剤
|
CA2503361C
(en)
*
|
2002-10-25 |
2012-02-28 |
Labopharm Inc. |
Controlled-release compositions
|
TWI319713B
(en)
|
2002-10-25 |
2010-01-21 |
|
Sustained-release tramadol formulations with 24-hour efficacy
|
MY142195A
(en)
*
|
2002-10-25 |
2010-10-15 |
Labopharm Inc |
Controlled-release compositions
|
DE10339864A1
(de)
*
|
2003-04-30 |
2005-01-20 |
Ipc Process-Center Gmbh & Co |
Coffein enthaltende Tablette
|
US20070048228A1
(en)
|
2003-08-06 |
2007-03-01 |
Elisabeth Arkenau-Maric |
Abuse-proofed dosage form
|
DE502004004205D1
(de)
*
|
2003-08-06 |
2007-08-09 |
Gruenenthal Gmbh |
Gegen missbrauch gesicherte darreichungsform
|
DE10336400A1
(de)
|
2003-08-06 |
2005-03-24 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
DE10361596A1
(de)
|
2003-12-24 |
2005-09-29 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
DE102004032051A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
DE102005005446A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Bruchfeste Darreichungsformen mit retardierter Freisetzung
|
US8075872B2
(en)
|
2003-08-06 |
2011-12-13 |
Gruenenthal Gmbh |
Abuse-proofed dosage form
|
US8377952B2
(en)
|
2003-08-28 |
2013-02-19 |
Abbott Laboratories |
Solid pharmaceutical dosage formulation
|
US8025899B2
(en)
|
2003-08-28 |
2011-09-27 |
Abbott Laboratories |
Solid pharmaceutical dosage form
|
US20060172006A1
(en)
*
|
2003-10-10 |
2006-08-03 |
Vincent Lenaerts |
Sustained-release tramadol formulations with 24-hour clinical efficacy
|
EP1715852A2
(de)
*
|
2004-01-06 |
2006-11-02 |
Panacea Biotec Ltd. |
Nichtzerfallende feste zusammensetzung hochdosierter wasserlöslicher arzneistoffe zur oralen anwendung
|
TWI350762B
(en)
*
|
2004-02-12 |
2011-10-21 |
Euro Celtique Sa |
Particulates
|
GB0403098D0
(en)
*
|
2004-02-12 |
2004-03-17 |
Euro Celtique Sa |
Extrusion
|
KR100582350B1
(ko)
*
|
2004-02-17 |
2006-05-22 |
한미약품 주식회사 |
탐수로신 염산염의 경구투여용 조성물 및 이의 서방성과립 제제
|
KR100574554B1
(ko)
*
|
2004-05-28 |
2006-04-27 |
한미약품 주식회사 |
니아신의 경구투여용 서방성 조성물
|
PL1750862T3
(pl)
|
2004-06-04 |
2011-06-30 |
Teva Pharma |
Kompozycja farmaceutyczna zawierająca irbesartan
|
DE102004032049A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
US20060088594A1
(en)
*
|
2004-10-08 |
2006-04-27 |
Pilgaonkar Pratibha S |
Highly compressible controlled delivery compositions of metformin
|
DE102005005449A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
MY148074A
(en)
*
|
2005-05-10 |
2013-02-28 |
Novartis Ag |
Pharmaceutical compositions comprising imatinib and a release retardant
|
EP1888038A2
(de)
*
|
2005-05-10 |
2008-02-20 |
Novartis AG |
Pharmazeutische zusammensetzungen für die modifizierte freisetzung von famciclovir
|
US8920837B2
(en)
|
2005-07-01 |
2014-12-30 |
Rubicon Research Private Limited |
Sustained release dosage form
|
EP1942875B1
(de)
*
|
2005-08-24 |
2015-08-12 |
Rubicon Research Private Limited |
Formulierung mit kontrollierter freisetzung
|
CA2616416A1
(en)
|
2005-09-09 |
2007-05-03 |
Labopharm, Inc. |
Trazodone composition for once a day adminisitiation
|
ZA200807571B
(en)
*
|
2006-03-01 |
2009-08-26 |
Ethypharm Sa |
Crush-resistant tablets intended to prevent accidental misuse and unlawful diversion
|
AU2012202717B2
(en)
*
|
2006-03-01 |
2014-06-26 |
Ethypharm |
Crush-resistant tablets intended to prevent accidental misuse and unlawful diversion
|
BRPI0709606B8
(pt)
|
2006-03-16 |
2021-05-25 |
Tris Pharma Inc |
suspensão líquida administrável oralmente com características de liberação modificada
|
ES2572180T3
(es)
*
|
2006-04-26 |
2016-05-30 |
Alphapharm Pty Ltd |
Formulaciones de liberación controlada que comprenden unidad(es) discreta(s) sin recubrimiento y una matriz de liberación prolongada
|
CA2655682A1
(en)
|
2006-08-03 |
2008-02-07 |
Nitec Pharma Ag |
Delayed-release glucocorticoid treatment of rheumatoid disease
|
SA07280459B1
(ar)
|
2006-08-25 |
2011-07-20 |
بيورديو فارما إل. بي. |
أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
|
US20080078406A1
(en)
*
|
2006-09-29 |
2008-04-03 |
Jessica Clayton |
Endotracheal tube and technique for using the same
|
US20100081672A1
(en)
*
|
2006-12-07 |
2010-04-01 |
Schering Corporation |
Ph sensitive matrix formulation
|
DE102007011485A1
(de)
*
|
2007-03-07 |
2008-09-11 |
Grünenthal GmbH |
Darreichungsform mit erschwertem Missbrauch
|
CN101686931B
(zh)
*
|
2007-06-06 |
2013-06-19 |
巴斯夫欧洲公司 |
用于制备可咀嚼片剂和锭剂的药物配制剂
|
EP2249811A1
(de)
|
2008-01-25 |
2010-11-17 |
Grünenthal GmbH |
Pharmazeutische dosierform
|
HUE030803T2
(en)
|
2008-05-09 |
2017-06-28 |
Gruenenthal Gmbh |
Process for the preparation of an intermediate powder formulation and a final solid dosage form using a spraying step \ t
|
EP2349218B1
(de)
|
2008-10-07 |
2013-09-18 |
Basf Se |
Verfahren zur herstellung oraler darreichungsformen mit kontrollierter freisetzung
|
NZ582836A
(en)
*
|
2009-01-30 |
2011-06-30 |
Nitec Pharma Ag |
Delayed-release glucocorticoid treatment of rheumatoid arthritis by improving signs and symptoms, showing major or complete clinical response and by preventing from joint damage
|
WO2010134097A2
(en)
*
|
2009-05-22 |
2010-11-25 |
Alkem Laboratories Ltd. |
Stable pharmaceutical compositions of olanzapine and process for their preparation
|
EP2456427B1
(de)
|
2009-07-22 |
2015-03-04 |
Grünenthal GmbH |
Heißschmelzextrudierte retardierte pharmazeutische Darreichungsform
|
PE20120572A1
(es)
|
2009-07-22 |
2012-06-06 |
Gruenenthal Chemie |
Forma de dosificacion de oxidacion estabilizada resistente a la manipulacion
|
EP2531176B1
(de)
|
2010-02-03 |
2016-09-07 |
Grünenthal GmbH |
Herstellung einer pulverförmigen pharmazeutischen zusammensetzung mittels eines extruders
|
NZ607392A
(en)
|
2010-09-02 |
2015-03-27 |
Gruenenthal Chemie |
Tamper resistant dosage form comprising inorganic salt
|
PE20131126A1
(es)
|
2010-09-02 |
2013-10-21 |
Gruenenthal Chemie |
Forma de dosificacion resistente a alteracion que comprende un polimero anionico
|
DK2736497T3
(da)
|
2011-07-29 |
2017-11-13 |
Gruenenthal Gmbh |
Stød-resistent tablet, der tilvejebringer en øjeblikkelig frigivelse af et lægemiddel.
|
EP2736495B1
(de)
|
2011-07-29 |
2017-08-23 |
Grünenthal GmbH |
Verfälschungssichere multipartikular-tablette, die eine sofortige wirkstofffreigabe bereitstellt
|
CN102908327B
(zh)
*
|
2011-08-05 |
2015-03-11 |
江苏恒瑞医药股份有限公司 |
伊伐布雷定或其可药用盐的缓释制剂
|
EP2768537B1
(de)
*
|
2011-10-18 |
2019-02-20 |
Purdue Pharma LP |
Acrylpolymerformulierungen
|
MX356421B
(es)
|
2012-02-28 |
2018-05-29 |
Gruenenthal Gmbh |
Forma de dosificacion resistente a la manipulacion indebida que comprende un compuesto farmacologicamente activo y un polimero anionico.
|
LT2838512T
(lt)
|
2012-04-18 |
2018-11-12 |
GrĆ¼nenthal GmbH |
Pažeidimui atspari ir dozės atpalaidavimo nuokrypiui atspari farmacinė vaisto forma
|
GB201207907D0
(en)
|
2012-05-04 |
2012-06-20 |
E Therapeutics Plc |
Treatment of depression
|
US10064945B2
(en)
|
2012-05-11 |
2018-09-04 |
Gruenenthal Gmbh |
Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
|
MX2015016254A
(es)
|
2013-05-29 |
2016-04-20 |
Gruenenthal Gmbh |
Forma de dosificacion resistente al uso indebido con perfil de liberacion bimodal.
|
US10154966B2
(en)
|
2013-05-29 |
2018-12-18 |
Grünenthal GmbH |
Tamper-resistant dosage form containing one or more particles
|
KR20160031526A
(ko)
|
2013-07-12 |
2016-03-22 |
그뤼넨탈 게엠베하 |
에틸렌-비닐 아세테이트 중합체를 함유하는 템퍼 내성 투여형
|
CA2931553C
(en)
|
2013-11-26 |
2022-01-18 |
Grunenthal Gmbh |
Preparation of a powdery pharmaceutical composition by means of cryo-milling
|
EP3142646A1
(de)
|
2014-05-12 |
2017-03-22 |
Grünenthal GmbH |
Manipulationssichere kapselformulierung mit tapentadol mit unmittelbarer freisetzung
|
US9872835B2
(en)
|
2014-05-26 |
2018-01-23 |
Grünenthal GmbH |
Multiparticles safeguarded against ethanolic dose-dumping
|
CN104586829A
(zh)
*
|
2014-12-26 |
2015-05-06 |
济南齐拓医药科技有限公司 |
一种盐酸沙格雷酯缓释制剂
|
WO2016170097A1
(en)
|
2015-04-24 |
2016-10-27 |
Grünenthal GmbH |
Tamper-resistant dosage form with immediate release and resistance against solvent extraction
|
EP3331501B1
(de)
*
|
2015-08-08 |
2019-09-11 |
Alfred E. Tiefenbacher (GmbH & Co. KG) |
Magensaftresistente formulierung mit posaconazol
|
US11590228B1
(en)
|
2015-09-08 |
2023-02-28 |
Tris Pharma, Inc |
Extended release amphetamine compositions
|
WO2017042325A1
(en)
|
2015-09-10 |
2017-03-16 |
Grünenthal GmbH |
Protecting oral overdose with abuse deterrent immediate release formulations
|
US10624888B2
(en)
*
|
2016-03-31 |
2020-04-21 |
SpecGx LLC |
Extended release, abuse deterrent dosage forms
|
US11590081B1
(en)
|
2017-09-24 |
2023-02-28 |
Tris Pharma, Inc |
Extended release amphetamine tablets
|